...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines.
【24h】

Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines.

机译:严重急性呼吸系统综合症(SARS)冠状病毒刺突蛋白上免疫显性位点的鉴定:对开发SARS诊断和疫苗的意义。

获取原文
获取原文并翻译 | 示例
           

摘要

The spike (S) protein of severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) is not only responsible for receptor binding and virus fusion, but also a major Ag among the SARS-CoV proteins that induces protective Ab responses. In this study, we showed that the S protein of SARS-CoV is highly immunogenic during infection and immunizations, and contains five linear immunodominant sites (sites I to V) as determined by Pepscan analysis with a set of synthetic peptides overlapping the entire S protein sequence against the convalescent sera from SARS patients and antisera from small animals immunized with inactivated SARS-CoV. Site IV located in the middle region of the S protein (residues 528-635) is a major immunodominant epitope. The synthetic peptide S(603-634), which overlaps the site IV sequence reacted with all the convalescent sera from 42 SARS patient, but none of the 30 serum samples from healthy blood donors, suggesting its potential application as an Ag for developing SARS diagnostics.This study also provides information useful for designing SARS vaccines and understanding the SARS pathogenesis.
机译:严重急性呼吸系统综合症(SARS)冠状病毒(SARS-CoV)的刺突(S)蛋白不仅负责受体结合和病毒融合,而且在SARS-CoV蛋白中还诱导了保护性Ab反应的主要Ag。在这项研究中,我们表明SARS-CoV的S蛋白在感染和免疫过程中具有高度免疫原性,并且包含5个线性免疫显性位点(I至V位),通过Pepscan分析确定,其中有一组合成肽与整个S蛋白重叠SARS患者恢复期血清的序列和灭活SARS-CoV免疫的小动物的抗血清。位于S蛋白中间区域(残基528-635)的位点IV是主要的免疫显性表位。合成的肽S(603-634),与IV位点序列重叠,与42位SARS患者的所有恢复期血清反应,但30位来自健康献血者的血清样本均未反应,表明其潜在的应用作为Ag来开发SARS诊断该研究还提供了设计SARS疫苗和了解SARS发病机理的有用信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号